Le Lézard
Classified in: Science and technology
Subject: ACC

Repurchase of Truecaller B shares in week 52, 2022


STOCKHOLM, Jan. 2, 2023 /PRNewswire/ -- During 27 December 2022 and 30 December 2022 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 198,458 own B shares (ISIN: SE0016787071) as part of the share buyback programme initiated by the board of directors.

The share buybacks form part of the share buyback programme announced by Truecaller on 23 September 2022. The share buyback programme will be executed between 23 September and up until the 2023 AGM, is being carried out in accordance "Emittentregelverket".

Truecaller B shares have been repurchased as follows:

Date:

Aggregated daily
volume (number of
shares):

Weighted average share
price per day (SEK):

Total daily transaction
value (SEK):

27 December 2022

0

0

0

28 December 2022

0

0

0

29 December 2022

145,606

32.8606

4,784,700.52

30 December 2022

52,852

32.8825

1,737,905.89

Total accumulated over week 52/2022

198,458

32.8664

6,522,606.41

Total accumulated during the buyback program

5,120,294

36.8637

188,753,211.87

All acquisitions have been carried out on Nasdaq Stockholm by SEB on behalf of Truecaller. Following the above acquisitions, Truecaller's holding of own shares amounts to 5,120,294 B shares and 5,100,000 C shares as of 30 December 2022. The total number of shares in Truecaller, including own shares, is 379,059,710 and the number of outstanding shares, excluding the own shares, is 368,839,416.

A full breakdown of the transactions is attached to this announcement.

For more information, please contact: 

Andreas Frid, Head of IR & Communication
+46 705 290800
[email protected]

About Truecaller:
Truecaller (TRUE B) is the leading global platform for verifying contacts and blocking unwanted communication. We enable safe and relevant conversations between people and make it efficient for businesses to connect with consumers. Fraud and unwanted communication are endemic to digital economies, especially in emerging markets. We are on a mission to build trust in communication. Truecaller is an essential part of everyday communication for more than 330 million active users, with half a billion downloads since launch and around 38 billion unwanted calls identified and blocked in 2021. Headquartered in Stockholm, since 2009, we are a co-founder led, entrepreneurial company, with a highly experienced management team. Truecaller is listed on Nasdaq Stockholm since 8 October 2021. For more information, please visit corporate.truecaller.com

The following files are available for download:

https://mb.cision.com/Main/20429/3691608/1760771.pdf

Press release TRUE SBB week 52 eng

https://mb.cision.com/Public/20429/3691608/a6b0f8fc9e6c307c.pdf

TRUECALLER transaktioner v 52

SOURCE Truecaller AB


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: